GlobeNewsWire - Novozymes A/S Class B (NZYM B) Novozymes and Chr. Hansen receive binding tax ruling that the proposed merger can be completed as a tax-exempt merger

NZYM B Novozymes A/S Class B

Novozymes and Chr. Hansen receive binding tax ruling that the proposed merger can be completed as a tax-exempt merger

Please read the announcement in the attachment

Attachment

24/01/2023

Underlying

NZYM BNovozymes A/S Class B

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Novozymes A/S Class B

PRESS RELEASE

Free

NZYM B Novozymes A/S C...

Andrew Taylor joins Novonesis’ Executive Leadership Team

Andrew Taylor joins Novonesis’ Executive Leadership Team Andrew Taylor will assume the role as EVP of Food & Beverage Biosolutions at Novonesis. Please read the full announcement in PDF. Attachment

April 22, 2025 1 EN

PRESS RELEASE

Free

NZYM B Novozymes A/S C...

Transactions under Novonesis’ share buyback program

Transactions under Novonesis’ share buyback program Please read the announcement in PDF Attachment

April 22, 2025 1 EN

PRESS RELEASE

Free

NZYM B Novozymes A/S C...

Transactions under Novonesis’ share buyback program

Transactions under Novonesis’ share buyback program Please read the announcement in PDF Attachment

April 14, 2025 1 EN

PRESS RELEASE

Free

NZYM B Novozymes A/S C...

Transactions under Novonesis’ share buyback program

Transactions under Novonesis’ share buyback program Please read the announcement in PDF Attachment

April 7, 2025 1 EN

PRESS RELEASE

Free

NZYM B Novozymes A/S C...

Resolutions from the Annual General Meeting 2025

Resolutions from the Annual General Meeting 2025 Today, the Annual General Meeting of Novonesis (Novozymes A/S) was conducted. The following resolutions were made: Approval of the audited Annual Report for 2024Approval of distribution of profit with payment of an ordinary dividend of DKK 4.20 (corresponding to approximately EUR 0.56) per A and B share. In addition to this year-end dividend, an interim dividend of DKK 2.00 (EUR ~0.27) was disbursed on September 3, 2024.Approval of the Remuneration Report for 2024 (advisory vote)Approval of the remuneration of members of the Board of Direc...

April 3, 2025 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

NZYM B Novozymes A/S Class B

Novozymes and Chr. Hansen receive binding tax ruling that the proposed merger can be completed as a tax-exempt merger

Novozymes and Chr. Hansen receive binding tax ruling that the proposed merger can be completed as a tax-exempt merger

Underlying

Reports on Novozymes A/S Class B

Andrew Taylor joins Novonesis’ Executive Leadership Team

Transactions under Novonesis’ share buyback program

Transactions under Novonesis’ share buyback program

Transactions under Novonesis’ share buyback program

Resolutions from the Annual General Meeting 2025

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe